Search research articles
Contact Us
Filters
Showing results (21-30 of 315) with videos related to
Page
of 32
Sort By:
Journal of Cardiac Failure
|
January 10, 2022
All-Cause Mortality as an End Point for Heart Failure With Preserved Ejection Fraction: Underperformance or Overambitious?
Parag Goyal, Andrew J Sauer, Michael W Rich
Rheumatology (Oxford, England)
|
December 25, 2019
Comment on: Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis: reply
Iris Navarro-Millán, Parag Goyal, Monika M Safford
Journal of the American Geriatrics Society
|
April 15, 2022
Heart failure and cognitive impairment: Complexity that requires a new approach
Lauren G Gilstrap, Eiran Z Gorodeski, Parag Goyal
Rheumatology (Oxford, England)
|
October 2, 2018
Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis
Iris Navarro-Millán, Parag Goyal, Monika M Safford
Journal of General Internal Medicine
|
May 16, 2020
Implementing a Proactive Deprescribing Approach to Prevent Adverse Drug Events
Timothy S Anderson, Parag Goyal, Zachary A Marcum
JACC. Advances
|
April 9, 2026
The Convergence of Aging and Cardiovascular Disease
Michael G Nanna, Parag Goyal, Abdulla A Damluji
Journal of Cardiac Failure
|
March 16, 2020
Age and Heart Failure Trials - Lessons from DAPA-HF
Michael W Rich, Parag Goyal, Daniel E Forman
Current Cardiovascular Risk Reports
|
July 18, 2017
Impact of Exercise Programs on Hospital Readmission Following Hospitalization for Heart Failure: A Systematic Review
Parag Goyal, Diana Delgado, Scott L Hummel, et al.
The American Journal of Medicine
|
May 29, 2021
Polypharmacy in Heart Failure: Progress But Also Problem
Parag Goyal, Sabrina Mangal, Ashok Krishnaswami, et al.
Cardiology Clinics
|
October 9, 2022
Geriatric Domains in Patients with Heart Failure with Preserved Ejection Fraction
Parag Goyal, Omar Zainul, Dylan Marshall, et al.
Page
of 32
Search research articles
Search
Showing results (21-30 of 315) with videos related to
Sort By:
Page
of 32
Journal of Cardiac Failure
|
January 10, 2022
All-Cause Mortality as an End Point for Heart Failure With Preserved Ejection Fraction: Underperformance or Overambitious?
Parag Goyal, Andrew J Sauer, Michael W Rich
Rheumatology (Oxford, England)
|
December 25, 2019
Comment on: Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis: reply
Iris Navarro-Millán, Parag Goyal, Monika M Safford
Journal of the American Geriatrics Society
|
April 15, 2022
Heart failure and cognitive impairment: Complexity that requires a new approach
Lauren G Gilstrap, Eiran Z Gorodeski, Parag Goyal
Rheumatology (Oxford, England)
|
October 2, 2018
Lipid screening and statins alongside disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis
Iris Navarro-Millán, Parag Goyal, Monika M Safford
Journal of General Internal Medicine
|
May 16, 2020
Implementing a Proactive Deprescribing Approach to Prevent Adverse Drug Events
Timothy S Anderson, Parag Goyal, Zachary A Marcum
JACC. Advances
|
April 9, 2026
The Convergence of Aging and Cardiovascular Disease
Michael G Nanna, Parag Goyal, Abdulla A Damluji
Journal of Cardiac Failure
|
March 16, 2020
Age and Heart Failure Trials - Lessons from DAPA-HF
Michael W Rich, Parag Goyal, Daniel E Forman
Current Cardiovascular Risk Reports
|
July 18, 2017
Impact of Exercise Programs on Hospital Readmission Following Hospitalization for Heart Failure: A Systematic Review
Parag Goyal, Diana Delgado, Scott L Hummel, et al.
The American Journal of Medicine
|
May 29, 2021
Polypharmacy in Heart Failure: Progress But Also Problem
Parag Goyal, Sabrina Mangal, Ashok Krishnaswami, et al.
Cardiology Clinics
|
October 9, 2022
Geriatric Domains in Patients with Heart Failure with Preserved Ejection Fraction
Parag Goyal, Omar Zainul, Dylan Marshall, et al.
Page
of 32